Hypo-METRICS Version 1.0

  • Research type

    Research Study

  • Full title

    Hypo-METRICS: Hypoglycaemia MEasurement, ThResholds and ImpaCtS

  • IRAS ID

    259415

  • Contact name

    Pratik Choudhary

  • Contact email

    pratik.choudhary@kcl.ac.uk

  • Sponsor organisation

    King's College London

  • Duration of Study in the UK

    2 years, 3 months, 29 days

  • Research summary

    Hypoglycaemia or low blood glucose is a major barrier to achieving optimal glucose control. New technology, such as continuous glucose monitors (CGM), help us to better identify hypoglycaemia and develop strategies to avoid it. These devices measure glucose in the interstitial fluid just under skin, rather than in the blood, and provide information not only on how low glucose is, but also for how long. Recent studies showed that over half of episodes of low glucose with these systems are not recognised by people with diabetes, and even people without diabetes can have sensor values that are in the hypoglycaemia range for a prolonged period. In this setting, with increasing use of these devices, we need to firstly better define hypoglycaemia using CGM; and then also evaluate the impact of symptomatic as well as asymptomatic episodes of low sensor glucose on a variety of clinical, patient related and health economic outcomes such as mood, quality of sleep and productivity.

    In this multi-national observational study, we will recruit 600 patients using insulin and use CGM devices that are blinded ( to avoid influencing participant behaviour) for 10 weeks, while we use a bespoke app to collect data information on symptomatic hypoglycaemia, as well as on a variety of parameters such as sleep, mood, and well-being. We can then analyse these data to identify the best threshold and duration of low sensor glucose that provides the best match to patient detected hypoglycaemia to provide a better definition of clinically relevant low sensor glucose. We will also evaluate the impact of symptomatic as well as asymptomatic low sensor glucose on the other parameters that we are assessing.
    We believe these data will guide our understanding of which low glucose events are harmful, and help assess differences in hypoglycaemia between treatments.

  • REC name

    South Central - Oxford B Research Ethics Committee

  • REC reference

    20/SC/0112

  • Date of REC Opinion

    12 Jun 2020

  • REC opinion

    Further Information Favourable Opinion